• News
  • Sport
  • TV
  • Radio
  • Education
  • TV Licences
  • Contact Us

For all official information and updates regarding COVID-19, visit the South African Department of Health's website at www.sacoronavirus.co.za

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION
Home Sci-tech

SAHPRA has processed 10 applications for Ivermectin use in COVID-19 treatment

3 February 2021, 6:22 PM  |
Zalene Merrington Zalene Merrington |  @SABCNews
SAHPRA says it does not have enough data to say if Ivermectin can save lives.

SAHPRA says it does not have enough data to say if Ivermectin can save lives.

Image: Reuters

SAHPRA says it does not have enough data to say if Ivermectin can save lives.

The South African Health Products Regulatory Authority (SAHPRA) says it has processed 10 applications for the use of Ivermectin for the treatment of COVID-19.

The body briefed Parliament’s Portfolio Committee on Health on the use of the anti-parasitic drug. The Chief Executive Officer of SAHPRA, Boitumelo Semete, has repeated that there is insufficient data to approve the drug for use in humans.

The drug has been used elsewhere in the world to treat the virus, during small clinical trials.

Earlier this week, lobby group, AfriForum obtained an order from the High Court in Johannesburg that doctors may administer the drug in case of emergency, without waiting for the SAHPRA’s approval.

SAHPRA says it has embarked on a compassionate access programme for those who want to use Ivermectin. Those who apply for the use of the drug must be a registered health practitioner.

Health facilities must be able to store it safely and a doctor prescribing the drug to a patient takes full responsibility for the effects.

Semete says in January they received nearly 30 applications and in February, seven.

“Those applications we have received before the programme, we would’ve rejected based on insufficiency of data. Since this programme, we are sitting with 10, already processed. Of those 10, we have authorised those for named patients and didn’t have to go back to ask for more information.”

SAHPRA reviewing new data on the use of Ivermectin to treat COVID-19:

SAHPRA Chairperson, Helen Rees, says the board is closely monitoring all developments around the drug.

“Everyone, every clinician, every researcher would say this must be ongoing, sympathetic to those who are desperate to find a way to enhance what is available. I can’t say that Ivermectin saves lives. We don’t have enough data to say, ‘yes, it works or no it doesn’t work.’ And then we would also need to say to you what is the dose, how frequently do you use it and so on.”

Chairperson of Parliament’s Portfolio Committee on Health, Sdumo Dhlomo, has pleaded for cool heads with regards to the distribution and use of Ivermectin.

“There is no unanimity among doctors, but the body that represents them say the stance and approach by SAHPRA, they are in full support. I think we have to agree and be cautious in that and assist because whatever happens they will be responsible for the safety of our citizens.”

Share article
Tags: CoronavirusSAHPRAIvermectin
Previous Post

Greyhound reaches end of the road

Next Post

Eastern Cape recruiting teachers ahead of reopening of schools

Related Posts

Test tubes labelled "monkeypox virus positive" seen in this illustration taken May 23, 2022.

Fourth case of Monkeypox identified in SA

15 August 2022, 4:50 PM
A vial of measles vaccine is checked at a field logistics base run by Doctors Without Borders (MSF) in the town of Boso-Manzi in Mongala province in the Democratic Republic of Congo February 27, 2020.

Zimbabwe blames measles surge on sect gatherings after 80 children die

15 August 2022, 3:01 AM
Mock-up vials labeled "Monkeypox vaccine" are seen in this illustration taken, May 25, 2022.

Americans flock to Canada for monkeypox vaccine

14 August 2022, 12:08 PM
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020.

Emergent receives FDA warning letter over quality control issues

14 August 2022, 2:11 AM

Weather warnings issued ahead of cold front in Western Cape

13 August 2022, 8:52 PM
A driver seen operating a tractor

Small scale farmers lament support from government in Saldanha

13 August 2022, 5:43 PM
Next Post
Schools reopen on 15 February.

Eastern Cape recruiting teachers ahead of reopening of schools

Most Viewed

  • 24hrs
  • Week
  • Month
  • EMS says fire at Bree Street Taxi Rank in Johannesburg has been extinguished
  • The public has until 18 May to make submissions on Icasa’s regulations for extension of expiry period for data, airtime
  • ANC NEC expected to hold a special meeting on Sunday
  • Eastern Cape flood victims plead for support as access to food, services remains difficult
  • Amathole Regional Secretary elated to have corruption charges against him dropped
  • Home Affairs clamps down on passport fraud and introduces transit visas
  • Home Affairs tightens rules on passport application to curb corruption
  • TEMBISA UNREST: ‘Police killed him because they thought he was taking a video’
  • Prince Simakade commits to working with members of the AmaZulu royal family
  • Zimbabwe to repatriate thousands of its nationals following cancellation of special permits
  • Home Affairs clamps down on passport fraud and introduces transit visas
  • Mogalakwena Municipality in Limpopo directed to terminate appointment of more than 400 workers
  • ANC Deputy Secretary General Jessie Duarte passes away
  • Home Affairs tightens rules on passport application to curb corruption
  • Siboniso Duma elected as the new ANC KZN chair

LATEST

Global Business Travel Group Inc, owner of the world's largest corporate travel agency American Express Global Business Travel, said last week that revenues this year were expected to average around 65% of 2019 levels, though that did not include the impact of a possible recession.
  • Business

Inflation, labour shortages to delay recovery in business travel spending – Industry forecast


A view shows the Zaporizhzhia Nuclear Power Plant in the course of Ukraine-Russia conflict outside the Russian-controlled city of Enerhodar in the Zaporizhzhia region, Ukraine August 4, 2022.
  • World
  • Russia, Ukraine conflict

Russia: Too dangerous for IAEA to go through Kyiv to visit Zaporizhzhia nuclear plant


Ukrainian and Russian-installed officials have traded accusations over who is responsible for attacks close to the Zaporizhzhia nuclear plant in southern Ukraine.
  • Russia, Ukraine conflict
  • Business

Ukraine calls on world to ‘show strength’ after shelling near nuclear plant


The US dollar index gained 0.79% to 106.52.
  • Business

Greenback gains, Aussie tumbles after weak Chinese data


A spokesperson for British Prime Minister Boris Johnson said it was "ludicrous" to suggest Salman Rushdie was responsible for the attack.
  • World

Iran says Rushdie and supporters to blame for attack


Former DA Free State Leader and member of Parliament Patricia Kopane.
  • Politics

Patricia Kopane resigns from DA, Parliament


Weather

  • About the SABC
  • Contact Us
  • Jobs
  • Advertise
  • Disclaimer
  • Site Map

SABC © 2022

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION

© 2022

Previous Greyhound reaches end of the road
Next Eastern Cape recruiting teachers ahead of reopening of schools